# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

- acknowledge government support

## FIELD OF THE INVENTION

- define invention scope

## BACKGROUND OF THE INVENTION

- describe COX-1 and COX-2 enzymes
- motivate need for new therapeutically active compounds

## SUMMARY OF THE INVENTION

- introduce compound of Formula (I)

## X2 is O or N,

- define compound structure

## DETAILED DESCRIPTION OF THE INVENTION

- introduce compounds of formula (I)

### I. COMPOUNDS OF FORMULA (I)

- define compounds of formula (I)

### X2 is O or N,

- define R1
- define R2
- define R3 and R4
- define proviso for X1 and X2
- specify embodiments for R1
- specify embodiments for R2
- specify embodiments for R7 and R8
- specify embodiments for R3 and R4

### II. SUBSET OF COMPOUNDS OF FORMULA (IA)

- define compounds of Formula (Ia)
- specify carbamoyl moiety
- describe substituents R1, R2, R3, R4, R5, R6, R7, R8
- provide examples of R1, R2, R3, R4, R5, R6, R7, R8
- specify phenyl ring A substitution
- describe R3 and R4 substituents
- provide combinations of substituents

### III. SUBSET OF COMPOUNDS OF FORMULA (IB)

- define compounds of Formula (Ib)
- specify reverse-carbamoyl moiety
- describe substituents R1, R2, R3, R5, R6, R7, R8, R9
- provide examples of R1, R2, R3, R5, R6, R7, R8, R9
- specify phenyl ring A substitution
- describe R3 substituents
- provide combinations of substituents

### IV. DEFINITIONS

- define general terms
- define halogen
- define alkyl
- define haloalkyl
- define unsaturated alkyl
- define cycloalkyl
- define heteroatom and heteroalkyl
- define aryl and heteroaryl
- define heteroaryl groups
- define aromatic ring
- define heteroaromatic ring
- define arylalkyl
- define substituted
- list substituents for alkyl and heteroalkyl radicals
- define substituted alkyl
- list substituents for aryl and heteroaryl groups
- define alkoxy
- define heterocycle

### V. PHARMACEUTICALLY ACCEPTABLE SALTS

- define pharmaceutically acceptable salts
- describe acid addition salts
- describe base salts
- list examples of salts
- describe solvates
- describe hydrates
- describe prodrugs
- describe isotopically labelled compounds
- describe stereoisomeric forms

### VI. MEDICAL USES OF COMPOUNDS OF FORMULA (I), (Ia), (Ib)

- describe medical uses of compounds
- describe inhibition of FAAH and COX enzymes
- describe treatment of diseases associated with FAAH and COX activity
- describe prophylactic or therapeutic treatment
- describe treatment of various cancers
- describe treatment of inflammatory diseases or pain
- describe combination therapies
- describe administration with radiation therapy

### VII. PHARMACEUTICAL COMPOSITIONS

- describe pharmaceutical compositions
- describe carriers and excipients
- describe oral dosage forms
- describe parenteral dosage forms
- describe topical dosage forms
- describe pulmonary dosage forms

### VIII. METHODS FOR PREPARING COMPOUNDS OF FORMULA (I), (Ia), (Ib)

- introduce synthetic techniques for compounds of Formula (I), (Ia), (Ib)
- describe linear sequence of reactions
- provide alternative synthetic methods
- outline carbamoylation reaction of compounds of formula (II)
- describe treatment of compounds of formula (IIa) with isocyanate
- describe treatment of compounds of formula (IIa) with triphosgene and amine
- outline preparation of compounds of formula (I) from compounds of formula (IIb)
- describe preparation of compounds of formula (II) by palladium-catalyzed reaction
- outline preparation of boronic acids or esters
- provide procedure for exemplary compounds according to Formula (I)
- describe carbamate intermediates synthesis
- describe reverse carbamate intermediates synthesis
- outline acidic hydrolysis of methyl ester functionalities
- describe preparation of intermediates 7a and 8a of Scheme 2
- describe preparation of intermediates 7b and 8b of Scheme 2
- introduce materials and methods
- describe solvents and reagents
- outline analytical techniques
- provide general procedure for preparing biphenyl intermediates
- provide general procedure for preparing carbamate intermediates
- provide general procedure for preparing reverse carbamate intermediates
- provide general procedure for preparing acid intermediates
- describe preparation of 2-(3-fluoro-4-nitro-phenyl)propanoic acid
- describe preparation of methyl 2-(4-amino-3-fluoro-phenyl)propanoate
- describe preparation of methyl 2-(3-fluoro-4-iodo-phenyl)propanoate and methyl 2-[3
- prepare compounds of formula (I), (Ia), (Ib)
- describe synthesis of methyl 2-[3-fluoro-4-(3-hydroxyphenyl)phenyl]propanoate derivatives
- synthesize methyl 2-[3-fluoro-4-(3-hydroxyphenyl)phenyl]propanoate
- synthesize methyl 2-[4-(3-aminophenyl)-3-fluoro-phenyl]propanoate
- synthesize methyl 2-[4-[3-(cyclohexylcarbamoyloxy)phenyl]-3-fluoro-phen
- synthesize methyl 2-[4-[3-(cyclopentylcarbamoyloxy)phenyl]-3-fluoro-phen
- synthesize methyl 2-[4-[3-(cyclobutylcarbamoyloxy)phenyl]-3-fluoro-phen
- synthesize methyl 2-[4-[3-(cyclopropylcarbamoyloxy)phenyl]-3-fluoro-phen
- prepare compound using general method D
- prepare compound using general method B
- prepare compound using general method D
- prepare compound using general method B
- prepare compound using general method D
- prepare compound using general method B
- prepare compound using general method D
- prepare compound using general method D
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize methyl 2-[3-fluoro-4-[3-(phenethylcarbamoyloxy)phenyl]phenyl]pro
- synthesize 2-[3-fluoro-4-[3-(phenethylcarbamoyloxy)phenyl]phenyl]propan
- synthesize methyl 2-[3-fluoro-4-[3-(3-phenylpropylcarbamoyloxyl)phenyl]
- synthesize 2-[3-fluoro-4-[3-(3-phenylpropylcarbamoyloxyl)phenyl]phen
- synthesize methyl 2-[3-fluoro-4-[3-(4-phenylbutylcarbamoyloxyl)phenyl]
- synthesize 2-[3-fluoro-4-[3-(4-phenylbutylcarbamoyloxyl)phenyl]phen
- synthesize other compounds of formula (I), (Ia), (Ib)
- prepare compounds of formula (I), (Ia), (Ib)
- prepare 2-[4-[3-(butylcarbamoyloxy)phenyl]-3-fluoro-phenyl]propano
- prepare methyl 2-[3-fluoro-4-[3-(pentylcarbamoyloxy)phenyl]phenyl]propan
- prepare 2-[3-fluoro-4-[3-(pentylcarbamoyloxy)phenyl]phenyl]propano
- prepare methyl 2-[3-fluoro-4-[3-(hexylcarbamoyloxy)phenyl]phenyl]propan
- prepare 2-[3-fluoro-4-[3-(hexylcarbamoyloxy)phenyl]phenyl]propano
- prepare methyl 2-[3-fluoro-4-[3-(heptylcarbamoyloxy)phenyl]phenyl]pro
- prepare 2-[3-fluoro-4-[3-(heptylcarbamoyloxy)phenyl]phenyl]propan
- prepare 3-[2-fluoro-4-(2-hydroxy-1-methyl-ethyl)phenyl]phenol and [3
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize methyl 2-(3-fluoro-4-hydroxy-phenyl)acetate
- synthesize methyl 2-[3-fluoro-4-(trifluoromethylsulfonyloxy)phenyl]acetate
- synthesize methyl 2-[3-fluoro-4-(3-hydroxyphenyl)phenyl]acetate
- synthesize methyl 2-[3-fluoro-4-[3-(hexylcarbamoyloxy)phenyl]phenyl]acet
- synthesize 2-[3-fluoro-4-[3-(hexylcarbamoyloxy)phenyl]phenyl]acetic
- synthesize other compounds of formula (I), (Ia), (Ib)
- describe advantages of compounds of formula (I), (Ia), (Ib)

